Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

FDA approves Rochester Medical's FemSoft Insert for female stress urinary incontinence

Oct. 5, 1999

New muscarinic antagonists developed at Roche

Oct. 4, 1999

Alpha1A/1L-adrenoceptor agonists disclosed for urinary incontinence, etc.

Oct. 1, 1999

Preclinical study results support potential of NK1 antagonist in treating micturition disorders

Sep. 23, 1999

Ortho-McNeil designs new prostate-selective alpha1a-adrenoceptor antagonists

Sep. 15, 1999

Synaptic and Merck & Co. discontinue development of oral treatment for BPH

Sep. 13, 1999

Wider therapeutic index predicted for Ditropan XL compared to conventional Ditropan

Sep. 10, 1999

NexMed reports progress with topical treatments for sexual dysfunction

Sep. 9, 1999

FibroGen and Taisho to collaborate on kidney fibrosis research

Sep. 8, 1999

YM-31758: a potent and selective inhibitor of human prostatic 5alpha-reductase

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...